Alcon [ALC] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Alcon
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alcon wins in 7 metrics, Intuitive Surgical wins in 12 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Alcon | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 40.84 | 67.08 | Alcon |
| Price-to-Book Ratio | 2.07 | 9.65 | Alcon |
| Debt-to-Equity Ratio | 23.63 | 0.00 | Intuitive Surgical |
| PEG Ratio | 26.11 | 2.76 | Intuitive Surgical |
| EV/EBITDA | 21.16 | 52.40 | Alcon |
| Profit Margin (TTM) | 11.28% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 13.30% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 13.30% | 30.47% | Intuitive Surgical |
| Return on Equity | 5.23% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | 2.74% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $1.41B | $1.30B | Alcon |
| 1-Year Return | -6.21% | -1.51% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 4.62 | 18.83 | Alcon |
| Enterprise Value | $49.36B | $166.94B | Intuitive Surgical |
| EV/Revenue Ratio | 4.97 | 18.26 | Alcon |
| Gross Profit Margin (TTM) | 55.92% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $20 | $26 | Intuitive Surgical |
| Earnings per Share (Diluted) | $2.25 | $7.16 | Intuitive Surgical |
| Beta (Stock Volatility) | 0.70 | 1.60 | Alcon |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alcon vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alcon | 2.26% | 4.75% | 3.40% | 0.85% | 0.63% | 7.99% |
| Intuitive Surgical | -0.43% | 0.21% | -7.15% | -14.68% | -21.25% | -8.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alcon | -6.21% | 35.03% | 56.32% | 65.57% | 65.57% | 65.57% |
| Intuitive Surgical | -1.51% | 127.01% | 97.74% | 738.64% | 1,479.43% | 5,823.36% |
Performance & Financial Health Analysis: Alcon vs Intuitive Surgical
| Metric | ALC | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $45.84B | $172.16B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,498,680 | 1,853,870 |
| 90 Day Avg. Volume | 1,604,603 | 2,048,940 |
| Last Close | $90.12 | $479.20 |
| 52 Week Range | $80.48 - $101.10 | $425.00 - $616.00 |
| % from 52W High | -10.86% | -22.21% |
| All-Time High | $101.10 (Sep 09, 2024) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -10.86% | -22.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.21% |
| Quarterly Earnings Growth | 0.41% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.29% |
| Operating Margin (TTM) | 0.13% | 0.30% |
| Return on Equity (TTM) | 0.05% | 0.16% |
| Debt to Equity (MRQ) | 23.63 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $44.39 | $49.79 |
| Cash per Share (MRQ) | $2.85 | $14.86 |
| Operating Cash Flow (TTM) | $2.12B | $2.83B |
| Levered Free Cash Flow (TTM) | $1.18B | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Alcon vs Intuitive Surgical
| Metric | ALC | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 40.84 | 67.08 |
| Forward P/E | 26.11 | 61.10 |
| PEG Ratio | 26.11 | 2.76 |
| Price to Sales (TTM) | 4.62 | 18.83 |
| Price to Book (MRQ) | 2.07 | 9.65 |
| Market Capitalization | ||
| Market Capitalization | $45.84B | $172.16B |
| Enterprise Value | $49.36B | $166.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.97 | 18.26 |
| Enterprise to EBITDA | 21.16 | 52.40 |
| Risk & Other Metrics | ||
| Beta | 0.70 | 1.60 |
| Book Value per Share (MRQ) | $44.39 | $49.79 |
Financial Statements Comparison: Alcon vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALC | ISRG |
|---|---|---|
| Revenue/Sales | $2.47B | $2.44B |
| Cost of Goods Sold | $1.09B | $822.10M |
| Gross Profit | $1.38B | $1.62B |
| Research & Development | $222.00M | $313.30M |
| Operating Income (EBIT) | $468.00M | $743.40M |
| EBITDA | $463.00M | $898.70M |
| Pre-Tax Income | $414.00M | $832.10M |
| Income Tax | $64.00M | $167.90M |
| Net Income (Profit) | $350.00M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALC | ISRG |
|---|---|---|
| Cash & Equivalents | $1.41B | $2.57B |
| Total Current Assets | $6.07B | $7.66B |
| Total Current Liabilities | $2.25B | $1.54B |
| Long-Term Debt | $5.02B | N/A |
| Total Shareholders Equity | $22.02B | $17.21B |
| Retained Earnings | N/A | $7.14B |
| Property, Plant & Equipment | $4.90B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALC | ISRG |
|---|---|---|
| Operating Cash Flow | N/A | $833.10M |
| Capital Expenditures | N/A | $-116.60M |
| Free Cash Flow | $384.00M | $465.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALC | ISRG |
|---|---|---|
| Shares Short | 6.89M | 4.30M |
| Short Ratio | 4.54 | 2.18 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 1,498,680 | 1,853,870 |
| Average Daily Volume (90 Day) | 1,604,603 | 2,048,940 |
| Shares Outstanding | 494.62M | 356.60M |
| Float Shares | 494.60M | 356.33M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.69% | 0.89% |
Dividend Analysis & Yield Comparison: Alcon vs Intuitive Surgical
| Metric | ALC | ISRG |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.17 | N/A |
| 3-Year Avg Dividend Yield | 0.30% | N/A |
| 3-Year Total Dividends | $0.50 | N/A |
| Ex-Dividend Date | May 14, 2024 | N/A |